Guobang Pharma Ltd. (SHA:605507)

China flag China · Delayed Price · Currency is CNY
24.22
+0.36 (1.51%)
Apr 29, 2026, 3:00 PM CST
27.34%
Market Cap 13.33B
Revenue (ttm) 6.09B
Net Income (ttm) 766.47M
Shares Out 558.82M
EPS (ttm) 1.39
PE Ratio 17.17
Forward PE n/a
Dividend 0.60 (2.50%)
Ex-Dividend Date Jun 13, 2025
Volume 3,075,400
Average Volume 3,764,746
Open 23.83
Previous Close 23.86
Day's Range 23.79 - 24.35
52-Week Range 18.93 - 29.98
Beta 0.41
RSI 40.31
Earnings Date Jul 30, 2026

About Guobang Pharma

Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 117 countries and regions worldwide. The company was founded in 1996 and is based in Xinchang, China. [Read more]

Sector Healthcare
Founded 1996
Employees 4,251
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 605507
Full Company Profile

Financial Performance

In 2025, Guobang Pharma's revenue was 6.01 billion, an increase of 2.05% compared to the previous year's 5.89 billion. Earnings were 820.82 million, an increase of 5.02%.

Financial Statements

News

There is no news available yet.